Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease.

Karlawish J.

Neurology. 2011 Oct 11;77(15):1487-93. doi: 10.1212/WNL.0b013e318232ac1a.

2.

Design of comprehensive Alzheimer's disease centers to address unmet national needs.

Trojanowski JQ, Arnold SE, Karlawish JH, Brunden K, Cary M, Davatzikos C, Detre J, Gaulton G, Grossman M, Hurtig H, Jedrziewski K, McCluskey L, Naylor M, Polsky D, Schellenberg GD, Siderowf A, Shaw LM, Van Deerlin V, Wang LS, Werner R, Xie SX, Lee VM.

Alzheimers Dement. 2010 Mar;6(2):150-5. doi: 10.1016/j.jalz.2009.11.004.

3.

[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].

Croisile B, Auriacombe S, Etcharry-Bouyx F, Vercelletto M; National Institute on Aging (u.s.).; Alzheimer Association..

Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Review. French.

PMID:
22579080
5.

Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.

Gauthier S, Leuzy A, Racine E, Rosa-Neto P.

Prog Neurobiol. 2013 Nov;110:102-13. doi: 10.1016/j.pneurobio.2013.01.003. Review.

PMID:
23578568
6.

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH.

Alzheimers Dement. 2011 May;7(3):280-92. doi: 10.1016/j.jalz.2011.03.003.

7.

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B, Phelps CH.

Alzheimers Dement. 2011 May;7(3):257-62. doi: 10.1016/j.jalz.2011.03.004.

8.

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH.

Alzheimers Dement. 2011 May;7(3):263-9. doi: 10.1016/j.jalz.2011.03.005.

9.

Early diagnostics and therapeutics for Alzheimer's disease--how early can we get there?

Monien BH, Apostolova LG, Bitan G.

Expert Rev Neurother. 2006 Sep;6(9):1293-306. Review.

10.

Confidentiality in preclinical Alzheimer disease studies: when research and medical records meet.

Arias JJ, Karlawish J.

Neurology. 2014 Feb 25;82(8):725-9. doi: 10.1212/WNL.0000000000000153.

11.

[New diagnostic guidelines for Alzheimer's disease by NIA/AA].

Ihara R.

Nihon Rinsho. 2016 Mar;74(3):386-94. Japanese.

PMID:
27025074
12.

Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society.

Small GW, Rabins PV, Barry PP, Buckholtz NS, DeKosky ST, Ferris SH, Finkel SI, Gwyther LP, Khachaturian ZS, Lebowitz BD, McRae TD, Morris JC, Oakley F, Schneider LS, Streim JE, Sunderland T, Teri LA, Tune LE.

JAMA. 1997 Oct 22-29;278(16):1363-71. Review.

PMID:
9343469
13.

State of the science: use of biomarkers and imaging in diagnosis and management of Alzheimer disease.

Fraller DB.

J Neurosci Nurs. 2013 Apr;45(2):63-70. doi: 10.1097/JNN.0b013e3182829024. Review.

PMID:
23353653
14.

Biomarkers for preclinical Alzheimer's disease.

Tan CC, Yu JT, Tan L.

J Alzheimers Dis. 2014;42(4):1051-69. doi: 10.3233/JAD-140843. Review.

PMID:
25024325
15.

Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot.

Hampel H, Lista S, Khachaturian ZS.

Alzheimers Dement. 2012 Jul;8(4):312-36. doi: 10.1016/j.jalz.2012.05.2116. Review.

PMID:
22748938
16.

Complementary and Alternative Medicine in the Context of Earlier Diagnoses of Alzheimer's Disease: Opening the Conversation to Prepare Ethical Responses.

Racine E, Forlini C, Aspler J, Chandler J.

J Alzheimers Dis. 2016;51(1):1-9. doi: 10.3233/JAD-150534. Review.

PMID:
26836152
17.

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.

Jack CR Jr, Knopman DS, Weigand SD, Wiste HJ, Vemuri P, Lowe V, Kantarci K, Gunter JL, Senjem ML, Ivnik RJ, Roberts RO, Rocca WA, Boeve BF, Petersen RC.

Ann Neurol. 2012 Jun;71(6):765-75. doi: 10.1002/ana.22628.

18.

Practical treatment strategies for patients with Alzheimer's disease.

Christensen DD, Lin P.

J Fam Pract. 2007 Dec;56(12 Suppl New):S17-23. Review.

PMID:
18664338
19.
20.

Implications of the Facing Dementia Survey for policy makers and third-party organisations across Europe.

Rimmer E, Stave C, Sganga A, O'Connell B.

Int J Clin Pract Suppl. 2005 Mar;(146):34-8.

PMID:
15801191
Items per page

Supplemental Content

Support Center